162 related articles for article (PubMed ID: 32186268)
1. A Review of IGF1 Signaling and IGF1-related Long Noncoding RNAs in Chemoresistance of Cancer.
Liu L; Li X
Curr Cancer Drug Targets; 2020; 20(5):325-334. PubMed ID: 32186268
[TBL] [Abstract][Full Text] [Related]
2. The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer.
Jin KT; Lu ZB; Lv JQ; Zhang JG
RNA Biol; 2020 Dec; 17(12):1727-1740. PubMed ID: 32129701
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNAs as biotargets in cisplatin-based drug resistance.
Abu N; Hon KW; Jeyaraman S; Jamal R
Future Oncol; 2018 Dec; 14(29):3085-3095. PubMed ID: 30468082
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs.
Jiang W; Xia J; Xie S; Zou R; Pan S; Wang ZW; Assaraf YG; Zhu X
Drug Resist Updat; 2020 May; 50():100683. PubMed ID: 32146422
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of lncRNA H19 sensitizes melanoma cells to cisplatin by regulating the miR-18b/IGF1 axis.
An LF; Huang JW; Han X; Wang J
Anticancer Drugs; 2020 Jun; 31(5):473-482. PubMed ID: 32265386
[TBL] [Abstract][Full Text] [Related]
6. Potential roles of exosome non‑coding RNAs in cancer chemoresistance (Review).
Wang Y; Liu Q; Wang F
Oncol Rep; 2021 Feb; 45(2):439-447. PubMed ID: 33416168
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA: A recently accentuated molecule in chemoresistance in cancer.
Peng Y; Tang D; Zhao M; Kajiyama H; Kikkawa F; Kondo Y
Cancer Metastasis Rev; 2020 Sep; 39(3):825-835. PubMed ID: 32594276
[TBL] [Abstract][Full Text] [Related]
8. Systematic identification of dysregulated lncRNAs associated with platinum-based chemotherapy response across 11 cancer types.
Zhu Y; Zhao Y; Dong S; Liu L; Tai L; Xu Y
Genomics; 2020 Mar; 112(2):1214-1222. PubMed ID: 31302201
[TBL] [Abstract][Full Text] [Related]
9. Emerging role of long non-coding RNAs in cancer chemoresistance: unravelling the multifaceted role and prospective therapeutic targeting.
Singh D; Khan MA; Siddique HR
Mol Biol Rep; 2020 Jul; 47(7):5569-5585. PubMed ID: 32601922
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNAs in the doxorubicin resistance of cancer cells.
Ashrafizaveh S; Ashrafizadeh M; Zarrabi A; Husmandi K; Zabolian A; Shahinozzaman M; Aref AR; Hamblin MR; Nabavi N; Crea F; Wang Y; Ahn KS
Cancer Lett; 2021 Jun; 508():104-114. PubMed ID: 33766750
[TBL] [Abstract][Full Text] [Related]
11. The role of long non-coding RNAs in drug resistance of cancer.
Zhang HD; Jiang LH; Zhong SL; Li J; Sun DW; Hou JC; Wang DD; Zhou SY; Tang JH
Clin Genet; 2021 Jan; 99(1):84-92. PubMed ID: 32583420
[TBL] [Abstract][Full Text] [Related]
12. LncRNA regulation: New frontiers in epigenetic solutions to drug chemoresistance.
Zhou Y; Sun W; Qin Z; Guo S; Kang Y; Zeng S; Yu L
Biochem Pharmacol; 2021 Jul; 189():114228. PubMed ID: 32976832
[TBL] [Abstract][Full Text] [Related]
13. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
15. The Emerging Role and Promise of Long Noncoding RNAs in Lung Cancer Treatment.
Chen Y; Li C; Pan Y; Han S; Feng B; Gao Y; Chen J; Zhang K; Wang R; Chen L
Cell Physiol Biochem; 2016; 38(6):2194-206. PubMed ID: 27183839
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNAs regulate drug resistance in cancer.
Liu K; Gao L; Ma X; Huang JJ; Chen J; Zeng L; Ashby CR; Zou C; Chen ZS
Mol Cancer; 2020 Mar; 19(1):54. PubMed ID: 32164712
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNAs in cancer drug resistance development.
Majidinia M; Yousefi B
DNA Repair (Amst); 2016 Sep; 45():25-33. PubMed ID: 27427176
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway.
Pan Y; Chen J; Tao L; Zhang K; Wang R; Chu X; Chen L
Oncotarget; 2017 May; 8(20):33144-33158. PubMed ID: 28388536
[TBL] [Abstract][Full Text] [Related]
19. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review).
Chen C; Tang X; Liu Y; Zhu J; Liu J
Int J Oncol; 2019 May; 54(5):1511-1524. PubMed ID: 30896792
[TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA TINCR-Mediated Regulation of Acetyl-CoA Metabolism Promotes Nasopharyngeal Carcinoma Progression and Chemoresistance.
Zheng ZQ; Li ZX; Guan JL; Liu X; Li JY; Chen Y; Lin L; Kou J; Lv JW; Zhang LL; Zhou GQ; Liu RQ; Chen F; He XJ; Li YQ; Li F; Xu SS; Ma J; Liu N; Sun Y
Cancer Res; 2020 Dec; 80(23):5174-5188. PubMed ID: 33067266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
